Negative regulation of interferon-β gene expression during acute and persistent virus infections

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Ye, Junqiang ^a   Maniatis, Tom ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLOHEXIMIDE; INTERFERON REGULATORY FACTOR 3; RIBAVIRIN; STAT1 PROTEIN; VIRUS PROTEIN V; ANTIVIRUS AGENT; IRF3 PROTEIN, MOUSE; PROTEIN SYNTHESIS INHIBITOR; V PROTEIN, SENDAI VIRUS; VIRUS PROTEIN;

ACUTE VIRUS INFECTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN TARGETING; SENDAI VIRUS INFECTION; SIGNAL TRANSDUCTION; TRANSCRIPTION TERMINATION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; AUTOIMMUNE DISEASE; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; RESPIROVIRUS INFECTION; SENDAI VIRUS; VIROLOGY;

SENDAI VIRUS;

ANIMALS; ANTIVIRAL AGENTS; AUTOIMMUNE DISEASES; CELL LINE; CYCLOHEXIMIDE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MICE; PROTEIN SYNTHESIS INHIBITORS; RESPIROVIRUS INFECTIONS; RIBAVIRIN; SENDAI VIRUS; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS DISEASES;

EID: 79958059274     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020681     Document Type: Article

References (88)

1. Sen GC, (2001) Viruses and interferons. Annu Rev Microbiol 55: 255-281.
2. Garcia-Sastre A, Biron CA, (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312: 879-882.
3. Le Bon A, Tough DF, (2002) Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14: 432-436.
4. Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, et al. (1998) Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol 63: 609-620.
5. Honda K, Takaoka A, Taniguchi T, (2006) Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.
6. Sun L, Liu S, Chen ZJ, SnapShot: pathways of antiviral innate immunity. Cell 140: 436-436 e432.
7. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
8. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, et al. (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205: 1601-1610.
9. Fujita T, (2009) A nonself RNA pattern: tri-p to panhandle. Immunity 31: 4-5.
10. Yoneyama M, Fujita T, (2009) RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227: 54-65.
11. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
12. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740.
13. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
14. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
15. Saha SK, Pietras EM, He JQ, Kang JR, Liu SY, et al. (2006) Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 25: 3257-3263.
16. Ford E, Thanos D, The transcriptional code of human IFN-beta gene expression. Biochim Biophys Acta 1799: 328-336.
17. Hall JC, Rosen A, Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol 6: 40-49.
18. Banchereau J, Pascual V, (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392.
19. Yoshida H, Okabe Y, Kawane K, Fukuyama H, Nagata S, (2005) Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 6: 49-56.
20. Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, et al. (2007) Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci U S A 104: 7500-7505.
21. Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, et al. (2008) The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 9: 930-936.
22. Cui J, Zhu L, Xia X, Wang HY, Legras X, et al. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141: 483-496.
23. Sun Z, Ren H, Liu Y, Teeling JL, Gu J, Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J Virol 85: 1036-1047.
24. Gack MU, Nistal-Villan E, Inn KS, Garcia-Sastre A, Jung JU, Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J Virol 84: 3220-3229.
25. Nistal-Villan E, Gack MU, Martinez-Delgado G, Maharaj NP, Inn KS, et al. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. J Biol Chem 285: 20252-20261.
26. Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, et al. (2008) NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451: 573-577.
27. You F, Sun H, Zhou X, Sun W, Liang S, et al. (2009) PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 10: 1300-1308.
28. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ, (2005) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102: 17717-17722.
29. Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, et al. (2007) DUBA: a deubiquitinase that regulates type I interferon production. Science 318: 1628-1632.
30. Heyninck K, Beyaert R, (1999) The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett 442: 147-150.
31. Huang J, Liu T, Xu LG, Chen D, Zhai Z, et al. (2005) SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways. EMBO J 24: 4018-4028.
32. Saitoh T, Tun-Kyi A, Ryo A, Yamamoto M, Finn G, et al. (2006) Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 7: 598-605.
33. Kim H, Seed B, The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3. Nat Immunol 11: 743-750.
34. Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, et al. (2008) HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373: 85-97.
35. Tanaka T, Grusby MJ, Kaisho T, (2007) PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 8: 584-591.
36. Keller AD, Maniatis T, (1991) Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 5: 868-879.
37. Whittemore LA, Maniatis T, (1990) Postinduction turnoff of beta-interferon gene expression. Mol Cell Biol 10: 1329-1337.
38. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, et al. (2009) Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 119: 3544-3555.
39. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, et al. (2009) Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119: 3556-3572.
40. Bhandari BN, Wright TL, (1995) Hepatitis C: an overview. Annu Rev Med 46: 309-317.
41. Gale M Jr, Foy EM, (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945.
42. Forsman A, Weiss RA, (2008) Why is HIV a pathogen? Trends Microbiol 16: 555-560.
43. Levy JA, (2009) HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 23: 147-160.
44. Evans CF, Redwine JM, Patterson CE, Askovic S, Rall GF, (2002) LCMV and the central nervous system: uncovering basic principles of CNS physiology and virus-induced disease. Curr Top Microbiol Immunol 263: 177-195.
45. Zuniga EI, Liou LY, Mack L, Mendoza M, Oldstone MB, (2008) Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. Cell Host Microbe 4: 374-386.
46. Faisca P, Desmecht D, (2007) Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date. Res Vet Sci 82: 115-125.
47. Virgin HW, Wherry EJ, Ahmed R, (2009) Redefining chronic viral infection. Cell 138: 30-50.
48. Lin OS, Keeffe EB, (2001) Current treatment strategies for chronic hepatitis B and C. Annu Rev Med 52: 29-49.
49. Herbeuval JP, Shearer GM, (2007) HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol 123: 121-128.
50. Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, et al. (2008) Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 14: 1077-1087.
51. Boasso A, Shearer GM, (2008) Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 126: 235-242.
52. Lin R, Heylbroeck C, Pitha PM, Hiscott J, (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18: 2986-2996.
53. Bibeau-Poirier A, Gravel SP, Clement JF, Rolland S, Rodier G, et al. (2006) Involvement of the IkappaB kinase (IKK)-related kinases tank-binding kinase 1/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation. J Immunol 177: 5059-5067.
54. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T, (1994) The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78: 773-785.
55. Fan CM, Maniatis T, (1990) A DNA-binding protein containing two widely separated zinc finger motifs that recognize the same DNA sequence. Genes Dev 4: 29-42.
56. Lin Y, Wong K, Calame K, (1997) Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 276: 596-599.
57. Ohinata Y, Payer B, O'Carroll D, Ancelin K, Ono Y, et al. (2005) Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 436: 207-213.
58. Yao LC, Blitz IL, Peiffer DA, Phin S, Wang Y, et al. (2006) Schnurri transcription factors from Drosophila and vertebrates can mediate Bmp signaling through a phylogenetically conserved mechanism. Development 133: 4025-4034.
59. Ren B, Chee KJ, Kim TH, Maniatis T, (1999) PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev 13: 125-137.
60. Sun Q, Sun L, Liu HH, Chen X, Seth RB, et al. (2006) The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24: 633-642.
61. Peters K, Chattopadhyay S, Sen GC, (2008) IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J Virol 82: 3500-3508.
62. Mori M, Yoneyama M, Ito T, Takahashi K, Inagaki F, et al. (2004) Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J Biol Chem 279: 9698-9702.
63. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, et al. (1998) Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J 17: 1087-1095.
64. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, et al. (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1: 507-518.
65. Tan SL, He Y, Huang Y, Gale M Jr, (2004) Strategies for hepatitis C therapeutic intervention: now and next. Curr Opin Pharmacol 4: 465-470.
66. Darnell JE Jr, Kerr IM, Stark GR, (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
67. Takeuchi K, Komatsu T, Yokoo J, Kato A, Shioda T, et al. (2001) Sendai virus C protein physically associates with Stat1. Genes Cells 6: 545-557.
68. Garcin D, Marq JB, Iseni F, Martin S, Kolakofsky D, (2004) A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability. J Virol 78: 8799-8811.
69. Marq JB, Brini A, Kolakofsky D, Garcin D, (2007) Targeting of the Sendai virus C protein to the plasma membrane via a peptide-only membrane anchor. J Virol 81: 3187-3197.
70. Panne D, Maniatis T, Harrison SC, (2007) An atomic model of the interferon-beta enhanceosome. Cell 129: 1111-1123.
71. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, et al. (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
72. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
73. Collins SE, Noyce RS, Mossman KL, (2004) Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78: 1706-1717.
74. tenOever BR, Servant MJ, Grandvaux N, Lin R, Hiscott J, (2002) Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J Virol 76: 3659-3669.
75. tenOever BR, Sharma S, Zou W, Sun Q, Grandvaux N, et al. (2004) Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J Virol 78: 10636-10649.
76. Kane M, Golovkina T, Common threads in persistent viral infections. J Virol 84: 4116-4123.
77. Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC, (2007) Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 81: 12696-12703.
78. Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC, (2006) Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80: 9192-9199.
79. Lu LL, Puri M, Horvath CM, Sen GC, (2008) Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J Biol Chem 283: 14269-14276.
80. Komatsu T, Takeuchi K, Yokoo J, Gotoh B, (2004) C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 325: 137-148.
81. Childs K, Stock N, Ross C, Andrejeva J, Hilton L, et al. (2007) mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359: 190-200.
82. Childs KS, Andrejeva J, Randall RE, Goodbourn S, (2009) Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J Virol 83: 1465-1473.
83. Kiyotani K, Sakaguchi T, Kato A, Nagai Y, Yoshida T, (2007) Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice. Virology 359: 82-91.
84. Kato A, Kiyotani K, Kubota T, Yoshida T, Tashiro M, et al. (2007) Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J Virol 81: 3264-3271.
85. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4: 491-496.
86. Ye J, Chen S, Maniatis T, Cardiac glycosides are potent inhibitors of interferon-beta gene expression. Nat Chem Biol 7: 25-33.
87. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, et al. (2007) Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315: 1274-1278.
88. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, et al. (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268: 726-731.